Lupin to divest entire stake in Japanese subsidiary Kyowa for over Rs 3,702 crore
Updated : November 12, 2019 01:36 PM IST
Lupin said its board has approved selling its entire stake in Japanese subsidiary Kyowa Pharmaceutical Industry to Japan-based private equity fund Unison Capital Partners
The Mumbai-based company has entered into a definitive agreement for sale of its entire stake (99.82 percent) in Kyowa, Lupin said in a statement.
Lupin's subsidiary Nanomi BV will divest its entire stake in Kyowa to Unison's entity Plutus Ltd for an enterprise value of Japanese Yen 57,361 million.
Have you signed up for Primo, our daily newsletter?It has all the stories and data on the market, business, economy and tech that you need to know.
THANK YOU! You made our day. See you every morningYOUR EMAIL IS ON ITS WAY. Check your inbox for future updates.
To keep watching CNBC-TV18, India's No. 1 English Business News Channel, call your Cable or DTH Operator and subscribe now for just Rs. 4 per month. You can also subscribe to CNBC-TV18 Prime HD for Re 1/- per month.Find out more